SCHEMBL4491437

SCHEMBL4491437

CC(C)(N)CN1CCSCC(NC(=O)O)C1=O

nearest known ligand 0.43

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
▸ SRC P12931 13/20 0.40
▸ CASP1 P29466 5/20 0.39
▸ CASP8 Q14790 4/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4491434 0.78 SRC (0.42) SRCCASP1CASP8
SCHEMBL5464440 0.74 — —
SCHEMBL14170742 0.73 SRC (0.34) SRCCASP1CASP8
SCHEMBL4501161 0.73 SRC (0.49) SRCCASP1CASP8
SCHEMBL7428585 0.73 CASP1 (0.43) SRCCASP1CASP8
SCHEMBL5217351 0.70 SRC (0.48) SRCCASP1CASP8
SCHEMBL4488508 0.69 SRC (0.54) SRC
SCHEMBL4484988 0.69 SRC (0.55) SRCCASP1CASP8
SCHEMBL5903395 0.69 SRC (0.42) SRCCASP1CASP8
SCHEMBL10833244 0.69 F2 (0.42) SRCCASP1CASP8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7550453-B2 Anticancer agents; colon cancer or hepatocellular carcinoma; analogs of bengamide where the caprolactam ring is changed and/or substituted e.g. N-(2-Methyl-3-oxo-2,3,4,5-tetrahydro-1H-2-benzazepin-4-yl)-(E)-(2R,3R,4S,5R)-3,4,5-trihydroxy-2-methoxy-8,8-dimethylnon-6-enamide AVENTIS PHARMA SA (FR) 2009-06-23 — — US disclosed
Send feedback